EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK

Estelle Leplus, Jamila Kacher, Dalil Hannani iD, Guillaume Vayssiere, Jean-Paul Molens, Karine Laulanier, Dan Georgess, Véronique Josserand iD, Philippe Saas iD, Séverine Planel, Laurence Chaperot iD, Joel Plumas iD

Immunology · 2026-12 · 179 (4) · 671-681

DOI: 10.1111/imm.70194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, online erschienen am 02.09.2026. Verfasst von Estelle Leplus und 11 weiteren Autor:innen. Beteiligte Einrichtung: PDC*Line Pharma SAS, Grenoble, France. Hauptthemen laut MEDLINE: Dendritic Cells, p38 Mitogen-Activated Protein Kinases, L-Selectin, ADAM17 Protein. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Etablissement Français du Sang, PDC*Line Pharma, Wallon Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmacytoid dendritic cells (PDCs) represent a crucial bridge between innate and adaptive immunity as they can recognise viruses and viral‐infected cells, secrete type I interferon and prime naive T‐cell responses. Like naive T cells, PDCs express CD62L, an essential molecule involved in the trans‐endothelial migration process, and are supposed to travel directly from blood to lymph nodes to prime naive T cells. We developed a therapeutic PDC line model (PDC*line) derived from a patient with blastic PDC neoplasm, and showing high antigen‐presentation capacities. PDC*line‐based vaccine was tested in clinical trials in melanoma and lung cancer. Efficient specific T lymphocyte priming was observed suggesting the efficient migration of injected PDC*line‐based vaccine to lymph nodes. Here, we investigated the mechanisms involved in this migration and its regulation. In humanised mice, our results demonstrated the efficient migration of the PDC‐based vaccine from blood to lymph nodes and its capacity to prime naive T cells. The expression of CD62L was evaluated following irradiation, which was mandatory in the vaccine manufacturing step and possibly important for its efficacy. CD62L was rapidly shed after irradiation of PDC*line cells and primary PDCs but not of NK‐T cells, demonstrating the cell specificity of the mechanism. Our results show that p38 MAP kinase, known to be activated in response to irradiation and ADAM17 metalloprotease are involved in the rapid CD62L shedding. This new pathway could participate to the regulation PDC transmigration through High Endothelial Venules and homing to secondary lymphoid organs in cellular stress conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic Cellsp38 Mitogen-Activated Protein KinasesL-SelectinADAM17 ProteinHumansAnimalsMiceCell MovementT-LymphocytesCancer Vaccines

Stichwörter der Autor:innen

ADAM17L‐selectinactive immunotherapycell migrationcell‐based vaccineimmunologyplasmacytoid dendritic cells

Substanzen

p38 Mitogen-Activated Protein KinasesL-SelectinADAM17 ProteinADAM17 protein, humanCancer Vaccines

Autor:innen und Institutionen

  • PDC*Line Pharma SAS, Grenoble, France.
  • Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.
  • Université Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Team Translational Immunology and Immunotherapy in Chronic Disease, Grenoble, France.
  • Recherche et Développement, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
  • TransCure bioServices, Archamps, France.
  • Université Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Optimal, Grenoble, France.

ORCID-Profile: Dalil Hannani, Véronique Josserand, Philippe Saas, Laurence Chaperot, Joel Plumas

Förderung

  • Etablissement Français du Sang
  • PDC*Line Pharma
  • Wallon Region
  • France Life Imaging

Zitieren

APA

Leplus, E., Kacher, J., Hannani, D., Vayssiere, G., Molens, J. P., Laulanier, K., Georgess, D., Josserand, V., Saas, P., Planel, S., Chaperot, L., & Plumas, J. (2026). Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK. Immunology, 179(4), 671-681. https://doi.org/10.1111/imm.70194

Vancouver

Leplus E, Kacher J, Hannani D, Vayssiere G, Molens JP, Laulanier K, et al. Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK. Immunology. 2026;179(4):671-681. doi:10.1111/imm.70194

BibTeX
@article{Leplus2026,
  author = {Leplus, Estelle and Kacher, Jamila and Hannani, Dalil and Vayssiere, Guillaume and Molens, Jean-Paul and Laulanier, Karine and Georgess, Dan and Josserand, Véronique and Saas, Philippe and Planel, Séverine and Chaperot, Laurence and Plumas, Joel},
  title = {Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK},
  journal = {Immunology},
  year = {2026},
  volume = {179},
  number = {4},
  pages = {671--681},
  doi = {10.1111/imm.70194}
}
Kostenlos starten →